Bio-Techne Corp. Stock
Bio-Techne Corp. Stock
Bio-Techne Corp. shows a slight decrease today, losing -€0.200 (-0.450%) compared to yesterday.
The stock is an absolute favorite of our community with 22 Buy predictions and no Sell predictions.
As a result the target price of 60 € shows a positive potential of 35.14% compared to the current price of 44.4 € for Bio-Techne Corp..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Bio-Techne Corp. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Bio-Techne Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bio-Techne Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bio-Techne Corp. | -0.450% | -0.893% | -12.079% | -22.783% | -11.200% | -35.652% | - |
| Haemonetics Corp. | -0.950% | -0.952% | 6.557% | - | -24.088% | - | - |
| Bio-Rad Labs Inc. A | 2.330% | 0.086% | 1.169% | 0.129% | -9.422% | -46.981% | -51.333% |
| Neogen Corp. | -3.730% | -4.908% | -17.112% | -8.824% | 26.016% | - | - |
Comments
Bio-Techne (TECH) had its "buy" rating reaffirmed by TD Cowen.
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne (NASDAQ:TECH) had its price target raised by analysts at Wells Fargo & Company from $70.00 to $76.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne (NASDAQ:TECH) had its "buy" rating reaffirmed by analysts at TD Cowen.
Show more
Ratings data for TECH provided by MarketBeat